↓ Skip to main content

CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): study protocol of a phase III…

Overview of attention for article published in Trials, February 2022
Altmetric Badge

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trial
Published in
Trials, February 2022
DOI 10.1186/s13063-022-06098-y
Pubmed ID
Authors

Raymond Stegeman, Maaike Nijman, Johannes M. P. J. Breur, Floris Groenendaal, Felix Haas, Jan B. Derks, Joppe Nijman, Ingrid M. van Beynum, Yannick J. H. J. Taverne, Ad J. J. C. Bogers, Willem A. Helbing, Willem P. de Boode, Arend F. Bos, Rolf M. F. Berger, Ryan E. Accord, Kit C. B. Roes, G. Ardine de Wit, Nicolaas J. G. Jansen, Manon J. N. L. Benders

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 13%
Unspecified 5 9%
Researcher 4 7%
Student > Bachelor 4 7%
Other 3 5%
Other 4 7%
Unknown 29 52%
Readers by discipline Count As %
Medicine and Dentistry 14 25%
Unspecified 5 9%
Neuroscience 2 4%
Psychology 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 3 5%
Unknown 29 52%